Foam sclerotherapy using polidocanol for balloon-occluded retrograde transvenous obliteration (BRTO)
- نوع فایل : کتاب
- زبان : انگلیسی
- مؤلف : Sun Young Choi, Jong Yun Won, Kyung Ah Kim, Do Yun Lee, Kwang-Hun Lee
- چاپ و سال / کشور: 2010
Description
Purpose To evaluate the clinical safety and effectiveness of foam sclerotherapy using polidocanol for the treatment of gastric fundal varices by balloon-occluded retrograde transvenous obliteration (BRTO). Materials and methods From November 2005 to June 2009, foam sclerotherapy using polidocanol for the treatment of gastric fundal varices by BRTO was performed in 16 patients (male/female 11:5; age range 46–84years, median 67years). Foam was made of 3% polidocanol (Aethoxysklerol; Kreussler Pharma, Wiesbaden, Germany), room air, and contrast media, with a ratio of 1:2:1, respectively. The amount of polidocanol (2–24mL; median 7mL) depended on the volume of varices. Results Technical success was achieved in 15 of 16 patients (93.8%). Technical failure occurred in one patient. All patients were without pain during sclerotherapy. One patient experienced pulmonary edema after the procedure but completely recovered with medical treatment. There was no procedure-related mortality. Patients were followed by endoscopy, computed tomography, or both. Four patients were lost to follow-up. Clinical success was achieved in 10 of 11 patients (91%). Rebleeding occurred in one case during follow-up. Conclusions Foam sclerotherapy using polidocanol is clinically safe and effective for the treatment of gastric fundal varices during BRTO.
Eur Radiol (2011) 21: 122–129 DOI 10.1007/s00330-010-1895-3 Received: 8 March 2010, Revised: 13 June 2010 Accepted: 23 June 2010, Published online: 26 August 2010
